Thyrocare Technologies Ltd
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.
- Market Cap ₹ 6,132 Cr.
- Current Price ₹ 1,161
- High / Low ₹ 1,178 / 630
- Stock P/E 67.1
- Book Value ₹ 101
- Dividend Yield 1.81 %
- ROCE 26.5 %
- ROE 17.4 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 139%
- Company's working capital requirements have reduced from 28.9 days to 22.0 days
Cons
- Stock is trading at 11.5 times its book value
- The company has delivered a poor sales growth of 9.56% over past five years.
- Company has a low return on equity of 13.8% over last 3 years.
- Promoters have pledged or encumbered 100% of their holding.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Part of BSE Healthcare BSE SmallCap BSE Allcap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
150 | 180 | 235 | 298 | 332 | 370 | 401 | 474 | 562 | 486 | 524 | 633 | |
81 | 109 | 140 | 182 | 193 | 222 | 233 | 304 | 330 | 371 | 388 | 446 | |
Operating Profit | 69 | 71 | 95 | 115 | 139 | 148 | 168 | 171 | 232 | 115 | 136 | 188 |
OPM % | 46% | 40% | 40% | 39% | 42% | 40% | 42% | 36% | 41% | 24% | 26% | 30% |
7 | 13 | 6 | -16 | 21 | 14 | -35 | 12 | 7 | 5 | 6 | 13 | |
Interest | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 3 | 5 | 5 | 3 |
Depreciation | 6 | 11 | 11 | 12 | 12 | 14 | 20 | 21 | 28 | 34 | 39 | 47 |
Profit before tax | 69 | 73 | 89 | 87 | 148 | 147 | 112 | 161 | 207 | 81 | 98 | 151 |
Tax % | 33% | 33% | 34% | 46% | 35% | 35% | 29% | 26% | 27% | 30% | 28% | 37% |
46 | 49 | 59 | 47 | 96 | 95 | 79 | 120 | 152 | 57 | 71 | 96 | |
EPS in Rs | 42.28 | 9.75 | 10.94 | 8.69 | 17.87 | 18.04 | 15.01 | 22.65 | 28.74 | 10.76 | 13.43 | 18.07 |
Dividend Payout % | 0% | 157% | 91% | 115% | 56% | 111% | 33% | 110% | 52% | 167% | 134% | 116% |
Compounded Sales Growth | |
---|---|
10 Years: | 13% |
5 Years: | 10% |
3 Years: | 4% |
TTM: | 21% |
Compounded Profit Growth | |
---|---|
10 Years: | 7% |
5 Years: | -3% |
3 Years: | -15% |
TTM: | 33% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | 23% |
1 Year: | 82% |
Return on Equity | |
---|---|
10 Years: | 20% |
5 Years: | 19% |
3 Years: | 14% |
Last Year: | 17% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 11 | 51 | 54 | 54 | 54 | 53 | 53 | 53 | 53 | 53 | 53 | 53 |
Reserves | 195 | 229 | 322 | 364 | 400 | 403 | 325 | 393 | 468 | 468 | 461 | 484 |
25 | 0 | 0 | 0 | 0 | 0 | 9 | 10 | 21 | 21 | 39 | 23 | |
14 | 14 | 39 | 26 | 31 | 32 | 55 | 73 | 55 | 70 | 68 | 116 | |
Total Liabilities | 246 | 293 | 414 | 444 | 485 | 488 | 442 | 528 | 597 | 612 | 620 | 676 |
87 | 83 | 93 | 89 | 103 | 108 | 112 | 119 | 149 | 157 | 159 | 158 | |
CWIP | 6 | 6 | 1 | 2 | 0 | 1 | 4 | 8 | 2 | 1 | 1 | 14 |
Investments | 119 | 162 | 266 | 299 | 315 | 289 | 239 | 274 | 259 | 274 | 291 | 284 |
33 | 42 | 55 | 54 | 68 | 89 | 88 | 127 | 186 | 180 | 169 | 221 | |
Total Assets | 246 | 293 | 414 | 444 | 485 | 488 | 442 | 528 | 597 | 612 | 620 | 676 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
46 | 36 | 67 | 89 | 112 | 97 | 136 | 111 | 106 | 120 | 155 | 191 | |
-52 | -21 | -19 | -40 | -48 | -3 | 27 | -53 | -12 | -32 | -80 | -55 | |
0 | -23 | -45 | -48 | -65 | -96 | -163 | -58 | -87 | -88 | -84 | -124 | |
Net Cash Flow | -6 | -7 | 3 | 1 | -1 | -3 | 1 | 0 | 6 | 1 | -9 | 12 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 12 | 9 | 11 | 7 | 10 | 11 | 14 | 34 | 60 | 63 | 28 | 40 |
Inventory Days | 54 | 47 | 54 | 64 | 66 | 54 | 60 | 50 | 54 | 63 | 106 | 93 |
Days Payable | 13 | 5 | 8 | 4 | 23 | 19 | 62 | 48 | 30 | 52 | 83 | 141 |
Cash Conversion Cycle | 53 | 51 | 57 | 68 | 53 | 46 | 12 | 37 | 84 | 74 | 51 | -9 |
Working Capital Days | 22 | 52 | 15 | 28 | 11 | 4 | -9 | 9 | 49 | 39 | 25 | 22 |
ROCE % | 33% | 27% | 27% | 29% | 33% | 31% | 36% | 37% | 41% | 15% | 18% | 26% |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
10 Jul - Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the Quarter ended June 30,2025.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
7 Jul - Copies of Newspaper Advertisement published on July 07, 2025, in Business Standard (English) and Navshakti (Marathi).
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015
5 Jul - Thyrocare announces 25th AGM on July 31, 2025, with annual report dispatch and dividend details.
-
Business Responsibility and Sustainability Reporting (BRSR)
5 Jul - Thyrocare files FY25 Business Responsibility and Sustainability Report detailing ESG and governance disclosures.
-
Intimation Of Record Date For Dividend
5 Jul - Record date fixed as July 25, 2025, for final dividend ₹21/share, payable after AGM approval.
Annual reports
Concalls
-
Apr 2025Transcript PPT REC
-
Jan 2025Transcript PPT
-
Oct 2024Transcript PPT
-
Jul 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
May 2021TranscriptNotesPPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Jul 2020TranscriptNotesPPT
-
May 2020TranscriptNotesPPT
-
Feb 2020TranscriptNotesPPT
-
Nov 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Jun 2019TranscriptPPT
-
May 2019TranscriptNotesPPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Aug 2018Transcript PPT
-
May 2018Transcript PPT
-
Feb 2018Transcript PPT
-
Dec 2017Transcript PPT
Business Segments
1) Diagnostic Testing Services (92% in FY25 vs 94% in FY22): [1] [2] The company is one of the leading Pan-India diagnostic chains, offering a range of tests focused on early disease detection and health management. It provides 929 tests and 288 profiles, including 43 wellness packages under the “Aarogyam” brand. It processes 3 Bn investigations annually and can process 10 Bn annually. [3] [4]